Human Monocytes - CD14, CD16 - Ziegler-Heitbrock

Contact

Exercise-induced modulation of monocytes in breast cancer survivors.

Abstract

Background: Exercise training reduces inflammation in breast cancer survivors; however, the mechanism is not fully understood. Objectives: The effects of acute and chronic exercise on monocyte toll-like receptor (TLR2 and 4) expression and intracellular cytokine production were examined in sedentary breast cancer survivors. Methods: Eleven women with stage I, II, or III breast cancer within one year of treatment completion performed an acute, intermittent aerobic exercise trial. Blood samples were obtained before, immediately, and 1 h after a 45-min acute exercise trial that was performed before and after 16 weeks of combined aerobic and resistance. LPS-stimulated intracellular IL-1ss, TNF, and IL-6 production, and TLR2 and TLR4 expression were evaluated in CD14+CD16- and CD14+CD16+ monocytes using flow cytometry. Results: Exercise training decreased IL-1ss+CD14+CD16- proportion (24.6%, p=0.016), IL-1ss+CD14+CD16- mean fluorescence intensity (MFI) (-9989, p=0.014), IL-1ss+CD14+CD16+ MFI (-11101, p=0.02), and IL-6+CD14+CD16- proportion (16.9%, P=0.04). TLR2 and TLR4 expression did not change following exercise training but decreased 1 h after acute exercise in CD14+CD16- (-63, p=0.002) and CD14+CD16+ (-18, p=0.006) monocytes, respectively. Immediately after the acute exercise, both monocyte subgroup cell concentration increased, with CD14+CD16+ concentrations being decreased at 1 h post without changes in intracellular cytokine production. Conclusions: Exercise training reduced monocyte intracellular pro-inflammatory cytokine production, especially IL-1ss, although these markers did not change acutely. While acute exercise downregulated the expression of TLR2 and TLR4 on monocytes, this was not sustained over the course of training. These results suggest that the anti-inflammatory effect of combined aerobic and resistance exercise training in breast cancer survivors may be, in part, due to reducing resting monocyte pro-inflammatory cytokine production.

Authors: Khosravi N, Hanson ED, Farajivafa V, Evans WS, Lee JT, Danson E, Wagoner CW, Harrell EP, Sullivan SA, Nyrop KA, Muss HB, Bartlett DB, Jensen BC, Haghighat S, Shamsi MM, Battaglini CL.
Journal: Brain Behav Immun Health. 2021 Mar 22;14:100216
Year: 2021
PubMed: PMID: 34589753 (Go to PubMed)